https://www.avient.com/company/sustainability/sustainability-report/metrics/planet-data-and-metrics
Home //
Sustainability //
Sustainability at Avient //
Metrics //
Planet Data and Metrics
https://www.avient.com/products/polymer-additives/healthcare-additives
Avient’s portfolio of healthcare additives helps enhance the performance and functionality of plastics used in drug delivery devices, in vitro diagnostic devices, and pharmaceutical packaging.
Avient’s portfolio of healthcare colorants includes standard and customized color solutions for a variety of polymers, from polyolefins, PC, PEBA, ABS, and styrenics to high temperature polysulfone resins.
https://www.avient.com/products/polymer-colorants/fiber-colorants
With global manufacturing footprint and capabilities, Avient is positioned to supply the textile industry with the highest quality colorants for fibers.
It's also vital to us at Avient.
https://www.avient.com/sites/default/files/2024-11/Avient Announces Registration Details for December 4th Investor Day.pdf
Microsoft Word - Avient Announces Registration Details for December 4th Investor Day _for Microsite 1 NEWS RELEASE FOR IMMEDIATE RELEASE Avient Announces Registration Details for December 4th Investor Day CLEVELAND – November 4, 2024 – Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable materials solutions, will host an Investor Day for the investment community on Wednesday, December 4, 2024, beginning at 10:00 a.m.
Ashish Khandpur, President and Chief Executive Officer of Avient Corporation.
Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com
https://www.avient.com/knowledge-base/article/beginner-s-guide-tpe
At Avient, we use a collaborative approach to deliver the specialty polymer formulations, services and sustainable material solutions specific to your application and property needs.
https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources.
As presented in previous slides, this presents potential benefits with respect to leverage and EBITDA margins PEER COMPARISONS 42 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.
Avient pro forma reflects 2022 estimated EBITDA of $660M and revenue of $3,740M.
https://www.avient.com/products/polymer-additives/electrical-performance-additives
Learn more about Avient's world-class services.
https://www.avient.com/products/polymer-additives/repellant-antimicrobial-additives
Add an extra level of protection to plastic products with Avient’s portfolio of repellant and antimicrobial additives.
https://www.avient.com/products/polymer-additives/barrier-and-scavenger-additives
It's also vital to us at Avient.
https://www.avient.com/sites/default/files/2021-02/avients-publication-of-uk-tax-strategy.pdf
This is in alignment with the Avient Code of Ethics.
Attitude of the Avient Group and level of risk the Avient Group accepts in relation to UK taxation The Avient Group does not engage in artificial tax arrangements.
Further information The Avient Group’s publication of its UK tax strategy is applicable to all members of the Avient Group.